Olympus Wins Award for Excellence at the Third Nikkei Integrated Report Awards

March 25, 2024

TOKYO, March 25, 2024 - Olympus Corporation (Olympus) has announced that its Integrated Report 2023 has received the Award for Excellence at the Third Nikkei Integrated Report Awards.

Since 2018, Olympus has been publishing an integrated report to communicate with investors, securities analysts, and all other stakeholders about how we create value in an easy-to-understand manner. The Olympus Integrated Report 2023 features the enthusiasm of the new CEO, Stefan Kaufmann, as well as a roundtable discussion with Chairperson of the Board Sumitaka Fujita, Executive Chairperson Yasuo Takeuchi, and Kaufmann, along with a message from the new management team. The judges commented, “The roundtable discussion included the background of the CEO change, important management issues at board meetings, and the ideal form of corporate governance for the company, and in addition, the belief that collaboration between the board and the executive team will lead to increased corporate value was evident. The ESG strategy, one of the important initiatives in the company strategy, is also explained in an easy-to-understand manner using diagrams and tables.” Olympus will continue its efforts to enhance corporate value and deepen external understanding of the company through proactively disclosing information and engaging in constructive dialogue with investors, securities analysts, and all other stakeholders.

The Olympus Integrated Report 2023 can be found on our website.

Intergrated report / Vice President of Investor Relations Takaaki Sakurai

About the Nikkei Integrated Report Awards

Nikkei has organized the prestigious Nikkei Annual Report Awards since 1998 to enhance and promote annual reports issued by Japanese companies. In recent years, annual reports have evolved and developed into "integrated reports" that incorporate non-financial information such as ESG and explain corporate values that have gained more attention. Responding to this transition, in 2021 Nikkei renamed the awards the Nikkei Integrated Report Awards, and their multi-layered evaluation system was reorganized and expanded.                     https://ps.nikkei.com/nira/index.html

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued the goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global Twitter account: @Olympus_Corp.

* Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.

* The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.

* Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.

* Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.

* All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. ® and TM marks are not specified in this website. All trademarks and registered trademarks are the property of their respective owners.